Aliskiren and dual therapy in type 2 diabetes mellitus

New England Journal of Medicine

Volumn 358, Issue 23, 2008, Pages 2503-2505

  Ingelfinger, Julie R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALISKIREN; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPLERENONE; HYDROCHLOROTHIAZIDE; RAMIPRIL; VALSARTAN;

BLOOD PRESSURE REGULATION; CLINICAL TRIAL; DRUG MECHANISM; EDITORIAL; HUMAN; HYPERTENSION; KIDNEY PRESERVATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TREATMENT OUTCOME;

EID: 44849124747     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe0803375     Document Type: Editorial

References (11)

1. Tigerstedt R, Bergman P. Niere und Kreislauf. Scand Arch Physiol 1898;8:223-71.
2. Atlas SA. The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition. J Manag Care Pharm 2007;13:Suppl B:9-20.
3. Jensen C, Herold P, Brunner HR. Aliskiren: the first renin inhibitor for clinical treatment. Nat Rev Drug Discov (in press).
4. Staessen JA, Li Y, Richart T. Oral renin inhibitors. Lancet 2006;368:1449-56. [Erratum, Lancet 2006;368:2124.]
5. Oparil S, Yarows SA, Patel S, Fang H, Zhang J, Satlin A. Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial. Lancet 2007;370:221-9. [Erratum, Lancet 2007;370:1542.]
6. Pool JL, Schmieder RE, Azizi M, et al. Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan. Am J Hypertens 2007;20:11-20.
7. Uresin Y, Taylor AA, Kilo C, et al. Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension. J Renin Angiotensin Aldosterone Syst 2007;8:190-8.
8. Kelly DJ, Zhang Y, Moe G, Naik G, Gilbert RE. Aliskiren, a novel renin inhibitor, is renoprotective in a model of advanced diabetic nephropathy in rats. Diabetologia 2007;50:2398-404.
9. Persson F, Rossing P, Schjoedt KJ, et al. Time course of antiproteinuric and antihypertensive effects of direct renin inhibition in type 2 diabetes. Kidney Int (in press).
10. Parving H-H, Persson F, Lewis JB, Lewis EJ, Hollenberg NK. Aliskiren combined with losartan in type 2 diabetes and nephropathy. N Engl J Med 2008;358:2433-46.
11. Berman N, Hostetter T. Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension. Am J Kidney Dis 2008;51:370-2.